China Healthwise Holdings Limited (HKG:0348)

Market Cap	53.93M
Revenue (ttm)	113.58M
Net Income (ttm)	-40.28M
Shares Out	770.48M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,280,000
Average Volume	910,610
Open	0.0690
Previous Close	0.0700
Day's Range	0.0690 - 0.0700
52-Week Range	0.0460 - 0.2100
Beta	-0.59
RSI	33.37
Earnings Date	Aug 26, 2025

About China Healthwise Holdings

China Healthwise Holdings Limited, an investment holding company, engages in the sale of Chinese health products in Hong Kong. It operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. The company sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers; and trades and retails Sum Yung and dried seafood under the Nam Pei Hong brand. It is also involved in money lending business; and invests in financial i...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1997
• Employees: 90
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0348

Financial Performance

In 2024, China Healthwise Holdings's revenue was 113.58 million, a decrease of -22.38% compared to the previous year's 146.32 million. Losses were -40.28 million, -70.06% less than in 2023.